Showing results (1-10 of 379) with videos related to
Sort By:
Pageof 38
Anti-Cancer Drugs|January 1, 1997
Protein kinase C: a worthwhile target for anticancer drugs?F Caponigro, R C French, S B KayeAnti-Cancer Drugs|April 22, 1999
First international conference on new molecular targets for anticancer therapy, Naples, 22-23 June 1998A Budillon, F CaponigroOncotargets and Therapy|July 10, 2010
The ubiquitin-proteasome system as a molecular target in solid tumors: an update on bortezomibA Milano, F Perri, F CaponigroInternational Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2001
The integration of docetaxel into first-line chemotherapy for ovarian cancerS B Kaye, International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Intravenous chemotherapy for ovarian cancer - the state of the art?S. B. KayeAnti-Cancer Drugs|January 12, 2000
Progress in the treatment of ovarian cancer. Scottish Gynaecological Cancer Trials GroupS B KayeJournal of the Royal College of Physicians of London|July 1, 1992
So, what is a clinical oncologist?S B KayeSeminars in Oncology|April 1, 1995
Docetaxel (Taxotere) in the treatment of solid tumors other than breast and lung cancerS B KayeBritish Journal of Cancer|August 26, 1998
New antimetabolites in cancer chemotherapy and their clinical impactS B KayeCancer Chemotherapy and Pharmacology|January 1, 1982
Intensive chemotherapy for solid tumours--current clinical applicationsS B KayePageof 38